ADVANCED ENZYME TECHNOLOGIES
Back to Income Statement
|
ADVANCED ENZYME TECHNOLOGIES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹133 Cr | ₹106 Cr | ₹120 Cr | ₹146 Cr | ₹129 Cr |
What is the latest Consolidated Net Profit of ADVANCED ENZYME TECHNOLOGIES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹133 Cr |
| Mar2024 | ₹106 Cr |
| Mar2023 | ₹120 Cr |
| Mar2022 | ₹146 Cr |
| Mar2021 | ₹129 Cr |
How is Consolidated Net Profit of ADVANCED ENZYME TECHNOLOGIES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹133 Cr | 26.19 | |
| Mar2024 | ₹106 Cr | -11.66 | |
| Mar2023 | ₹120 Cr | -18.06 | |
| Mar2022 | ₹146 Cr | 12.87 | |
| Mar2021 | ₹129 Cr | - | |
Compare Consolidated Net Profit of peers of ADVANCED ENZYME TECHNOLOGIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ADVANCED ENZYME TECHNOLOGIES | ₹3,270.3 Cr | 2.8% | 1.8% | 9.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,999.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,139.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,791.0 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,664.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| CIPLA | ₹107,685.0 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
ADVANCED ENZYME TECHNOLOGIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ADVANCED ENZYME TECHNOLOGIES | 2.8% |
1.8% |
9.9% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses